Found: 60
Select item for more details and to access through your institution.
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 8, p. 814, doi. 10.1001/jamaneurol.2024.1961
- By:
- Publication type:
- Article
Frequent detection of IFN-gamma-producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1416074
- By:
- Publication type:
- Article
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 5, p. 490, doi. 10.1001/jamaneurol.2024.0395
- By:
- Publication type:
- Article
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2871, doi. 10.1007/s00415-023-12175-2
- By:
- Publication type:
- Article
Clinical correlates of respiratory disorders in patients with severe multiple sclerosis: A cross-sectional cohort.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 6, p. 726, doi. 10.1177/13524585241238840
- By:
- Publication type:
- Article
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 3, p. 273, doi. 10.1001/jamaneurol.2023.5566
- By:
- Publication type:
- Article
Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational study.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2023.1303874
- By:
- Publication type:
- Article
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 2, p. 729, doi. 10.1007/s00415-023-12055-9
- By:
- Publication type:
- Article
Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks.
- Published in:
- Annals of Intensive Care, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13613-023-01213-x
- By:
- Publication type:
- Article
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 10, p. 1080, doi. 10.1001/jamaneurol.2023.2815
- By:
- Publication type:
- Article
Vaccines and the Risk of Hospitalization for Multiple Sclerosis Flare-Ups.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 10, p. 1098, doi. 10.1001/jamaneurol.2023.2968
- By:
- Publication type:
- Article
Association between vaccination and the risk of central demyelination: results from a case-referent study.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 10, p. 4678, doi. 10.1007/s00415-023-11822-y
- By:
- Publication type:
- Article
Relevance of kappa free light chains index in patients with aquaporin‐4 or myelin‐oligodendrocyte‐glycoprotein antibodies.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 9, p. 2865, doi. 10.1111/ene.15897
- By:
- Publication type:
- Article
Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 270, doi. 10.1177/13524585221134214
- By:
- Publication type:
- Article
Validation of the French version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire 15 Tools which help nurse for assessing the effect of perceived multiple sclerosis symptoms on sexual activity and satisfaction.
- Published in:
- Nursing Open, 2023, v. 10, n. 2, p. 570, doi. 10.1002/nop2.1323
- By:
- Publication type:
- Article
Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 10, p. 5647, doi. 10.1007/s00415-022-11130-x
- By:
- Publication type:
- Article
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study.
- Published in:
- Neurology & Therapy, 2022, v. 11, n. 2, p. 633, doi. 10.1007/s40120-022-00334-y
- By:
- Publication type:
- Article
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2280, doi. 10.1177/13524585211006372
- By:
- Publication type:
- Article
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 10, p. 2025, doi. 10.1002/acn3.51451
- By:
- Publication type:
- Article
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 10, p. 3461, doi. 10.1111/ene.14612
- By:
- Publication type:
- Article
Human papillomavirus lesions in 16 MS patients treated with fingolimod: Outcomes and vaccination.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 11, p. 1794, doi. 10.1177/1352458521991433
- By:
- Publication type:
- Article
Untreated patients with multiple sclerosis: A study of French expert centers.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 6, p. 2026, doi. 10.1111/ene.14790
- By:
- Publication type:
- Article
Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.628375
- By:
- Publication type:
- Article
The long‐term outcome of MOGAD: An observational national cohort study of 61 patients.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 5, p. 1659, doi. 10.1111/ene.14746
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML.
- Published in:
- 2021
- By:
- Publication type:
- journal article
COVID-19 infection in NMO/SD patients: a French survey.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease.
- Published in:
- Annals of Neurology, 2021, v. 89, n. 1, p. 30, doi. 10.1002/ana.25909
- By:
- Publication type:
- Article
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 9, p. 1079, doi. 10.1001/jamaneurol.2020.2581
- By:
- Publication type:
- Article
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 8, p. 936, doi. 10.1177/1352458519849511
- By:
- Publication type:
- Article
False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 5, p. 1182, doi. 10.1007/s00415-019-09248-6
- By:
- Publication type:
- Article
Efficacy of rituximab in refractory RRMS.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 6, p. 828, doi. 10.1177/1352458518772748
- By:
- Publication type:
- Article
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 4, p. 806, doi. 10.1007/s00415-018-9160-9
- By:
- Publication type:
- Article
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 4, p. 816, doi. 10.1007/s00415-019-09215-1
- By:
- Publication type:
- Article
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Sclérose en plaques chez le sujet âgé.
- Published in:
- Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 2017, v. 15, n. 4, p. 402, doi. 10.1684/pnv.2017.0685
- By:
- Publication type:
- Article
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1377, doi. 10.1177/1352458516678474
- By:
- Publication type:
- Article
Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center.
- Published in:
- Frontiers in Neurology, 2017, v. 8, p. 1, doi. 10.3389/fneur.2017.00183
- By:
- Publication type:
- Article
Extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Anxiety, emotional processing and depression in people with multiple sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 13, p. 1719, doi. 10.1177/1352458516667568
- By:
- Publication type:
- Article
Extensive and severe CNS demyelination associated with golimumab therapy.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Integrated multidisciplinary clinics should be the gold standard in managing progressive MS – NO.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1128, doi. 10.1177/1352458516643397
- By:
- Publication type:
- Article
Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The neuronal component of gray matter damage in multiple sclerosis: A [(11) C]flumazenil positron emission tomography study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Fecundity in women with multiple sclerosis: an observational mono-centric study.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 4, p. 957, doi. 10.1007/s00415-015-7663-1
- By:
- Publication type:
- Article